Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin.

ABSTRACT:

Introduction

Dysferlin loss-of-function mutations cause muscular dystrophy, accompanied by impaired membrane repair and muscle weakness. Growth promoting strategies including insulin-like growth factor 1 (IGF-1) could provide benefit but may cause strength loss or be ineffective. The objective of this study was to determine whether locally increased IGF-1 promotes functional muscle hypertrophy in dysferlin-null (Dysf^-/- ) mice.

Methods

Muscle-specific transgenic expression and postnatal viral delivery of Igf1 were used in Dysf^-/- and control mice. Increased IGF-1 levels were confirmed by enzyme-linked immunosorbent assay. Testing for skeletal muscle mass and function was performed in male and female mice.

Results

Muscle hypertrophy occurred in re

SUBMITTER: Barton ER 

PROVIDER: S-EPMC6771521 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature